Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 1999, p. 4825-4831, Vol. 19, No. 7
Department of
Pathology,1 Immunology
Program,2 M.D./Ph.D.
Program,3 and Department of
Microbiology and Molecular Biology,4 Tufts
University School of Medicine, Boston, Massachusetts 02111
Received 22 December 1998/Returned for modification 1 February
1999/Accepted 22 April 1999
Transformation of pre-B cells by Abelson murine leukemia virus
(Ab-MLV) involves a balance between positive, growth-stimulatory signals from the v-Abl oncoprotein and negative regulatory cues from
cellular genes. This phenomenon is reflected by the clonal selection
that occurs during Ab-MLV-mediated transformation in vivo and in vitro.
About 50% of all Ab-MLV-transformed pre-B cells express mutant forms
of p53 as they emerge from this process, suggesting that this protein
may play an important role in the transformation process. Consistent
with this idea, expression of p19Arf, a protein whose
function depends on the presence of a functional p53, is required for
the apoptotic crisis that characterizes primary Ab-MLV transformants.
To test the role of p53 in pre-B-cell transformation directly, we
examined the response of Trp53
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
p53 Mediates Apoptotic Crisis in Primary
Abelson Virus-Transformed Pre-B Cells
/
mice to
Ab-MLV. The absence of p53 shortens the latency of Abelson disease
induction but does not affect the frequency of cells susceptible to
Ab-MLV-induced transformation. However, primary transformants derived
from the null animals bypass the apoptotic crisis that characterizes
the transition from primary transformant to fully malignant cell line.
These effects do not require p21Cip-1, a major downstream
target of p53; however, consistent with a role of p19Arf,
transformants expressing mutant p53 and abundant p19 retain wild-type
p19 sequences.
*
Corresponding author. Mailing address: SC315, Tufts
University School of Medicine, 136 Harrison Ave., Boston, MA 02111. Phone: (617) 636-6906. Fax: (617) 636-0337. E-mail:
nrosenbe{at}opal.tufts.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|